AI-Driven Biomarkers in Pediatric Neuropathology

AI is advancing the identification and analysis of biomarkers in pediatric neuropathology, aiding in the early diagnosis and monitoring of neurological disorders. By analyzing tissue samples and imaging data, machine learning algorithms can detect subtle changes that may indicate disease progression or response to treatment. This session will focus on how AI is uncovering new biomarkers for conditions like brain tumors, neurodegenerative diseases, and genetic disorders, improving diagnosis and personalized care for pediatric patients.

    Related Conference of AI-Driven Biomarkers in Pediatric Neuropathology

    December 22-23, 2025

    4th International Conference on Neonatology

    Barcelona, Spain
    January 26-27, 2026

    27th World Congress on Pediatric Oncology and Cancer Care

    Edinburgh, Scotland
    February 23-24, 2026

    6th Global Summit on Pediatric Nursing

    Dubai, UAE
    February 23-24, 2026

    25th Annual World Congress on Neonatology

    Dubai, UAE
    February 26-27, 2026

    10th World Pediatrics Conference

    Amsterdam, Netherlands
    March 17-18, 2026

    5th World Congress on Pediatric Cardiology

    Amsterdam, Netherlands
    March 23-24, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    April 16-17, 2026

    5th International Congress on Pediatrics

    Tokyo, Japan
    April 20-21, 2026

    3rd World Congress on Pediatrics and Nutrition

    Paris, France
    April 23-24, 2026

    11th Annual Pediatric Congress

    Paris, France
    May 21-22, 2026

    39th World Pediatrics Conference

    Paris, France
    May 27-28, 2026

    38th European Pediatrics Congress

    Paris, France
    June 04-05, 2026

    30th World Nutrition and Pediatrics Healthcare Conference

    Zurich, Switzerland

    AI-Driven Biomarkers in Pediatric Neuropathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in